NUGS (Cannabis Strategic Ventures) Research & Development: $0.00 Mil (TTM As of Jun. 2020)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Cannabis Strategic Ventures Research & Development?

Cannabis Strategic Ventures NUGS Research & Development is $0.00 Mil as of Jun. 2020.

Research & Development is the aggregate amount of research and development expenses during the year. Cannabis Strategic Ventures's Research & Development for the three months ended in Jun. 2020 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2020 was $0.00 Mil.

Cannabis Strategic Ventures  (OTCPK:NUGS) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Cannabis Strategic Ventures Research & Development Related Terms

Cannabis Strategic Ventures Research & Development Historical Data

* Premium members only.

The historical data trend for Cannabis Strategic Ventures's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cannabis Strategic Ventures Research & Development Chart

Cannabis Strategic Ventures Annual Data
Trend Dec13 Dec14 Mar16 Mar17 Mar18 Mar19 Mar20
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Cannabis Strategic Ventures Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Cannabis Strategic Ventures Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.00 Mil mean?
Cannabis Strategic Ventures (NUGS) has a Research & Development of $0.00 Mil as of Jun. 2020. Research and development expense is the total cost for research and development activities. View historical data on Cannabis Strategic Ventures and its competitors.
Is Cannabis Strategic Ventures' Research & Development too high?
Cannabis Strategic Ventures' current Research & Development is $0.00 Mil.
How does Cannabis Strategic Ventures' Research & Development compare to RDGC and AKRX?
Cannabis Strategic Ventures' Research & Development of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Cannabis Strategic Ventures and its competitors. Cannabis Strategic Ventures's current Research & Development is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannabis Strategic Ventures stock overvalued right now?
Cannabis Strategic Ventures (NUGS) has a current Research & Development of $0.00 Mil. The current Research & Development is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Cannabis Strategic Ventures (NUGS), the current Research & Development is $0.00 Mil as of Jun. 2020. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cannabis Strategic Ventures Business Description

Address 9350 Wilshire Boulevard, Suite 203, Beverly Hills, CA, USA, 90212
Cannabis Strategic Ventures focuses on the medical and legal recreational cannabis sector. It provides temporary, permanent, and long-term staffing solutions, employment and human resources consulting to the legal Cannabis sector.